To investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet have done a 20-year follow-up of premenopausal women with breast cancer. The study, published in the Journal of Clinical ...
Aug 2, 2022
0
11
Wake Forest Institute for Regenerative Medicine (WFIRM) researchers are using a tumor organoid system to examine the effects of metabolites secreted by bacteria on a specialized immunotherapy—immune checkpoint blockage, ...
Jul 29, 2022
0
57
PIK3CA is a gene that makes an enzyme called PI3K, which is involved in many important cell functions. When PIK3CA mutates, however, it can make the PI3K enzyme become overactive and cause cancer cells to grow.
Jul 8, 2022
0
71
Two new innovations could make it easier for doctors to decipher when cancers that impact women are present and need urgent attention:
Jul 6, 2022
0
4
Having a baby after breast cancer does not negatively impact a woman's chance of surviving the disease. A new study shows that survival is no worse in younger women, those who had not been pregnant before, and those with ...
Jul 5, 2022
0
19
Progress towards a unique vaccine targeting specific breast cancer antigens has been shown to delay tumor growth and prevent breast cancer metastasis in preclinical models in a study led by the Malaghan Institute of Medical ...
Jul 5, 2022
0
11
Research led by Suresh Alahari, Ph.D., Professor of Biochemistry at LSU Health New Orleans schools of Medicine and Graduate Studies, suggests a combination of drugs already approved by the FDA for other cancers may be effective ...
Jun 29, 2022
0
39
The treatment of breast cancer abounding in the protein HER2 was revolutionized with the introduction of drugs like trastuzumab (Herceptin) that target the protein. When researchers discovered that breast cancers with lower ...
Jun 24, 2022
0
8
Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable and often not durable. Looking to better understand the underlying cause of this variation, a team led by researchers at Baylor ...
Jun 23, 2022
0
6
Delivering a targeted immunotoxin into breast ducts via openings in the nipple wiped out all visible and invisible precancerous lesions in laboratory studies, led by researchers at the Johns Hopkins Kimmel Cancer Center, ...
Jun 22, 2022
0
357
